Article Details
Retrieved on: 2021-07-10 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Needham analyst ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here